Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Boguniewicz

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Allergy and Clinical Immunology|April 15, 2011
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitisAnna De Benedetto, Mark K Slifka, Nicholas M Rafaels, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 23, 2023
Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis SkinDonald Y M Leung, Robert Bissonnette, Simion Kreimer, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 14, 2004
Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice ParametersDonald Y M Leung, Richard A Nicklas, James T Li, et al.
Allergy|July 11, 2022
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitisEvgeny Berdyshev, Elena Goleva, Robert Bissonnette, et al.
Dermatology and Therapy|June 2, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) RegistryEric L Simpson, Anna De Benedetto, Mark Boguniewicz, et al.
American Journal of Clinical Dermatology|December 12, 2019
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical TrialAmy S Paller, Ashish Bansal, Eric L Simpson, et al.
The Journal of Allergy and Clinical Immunology|September 29, 2024
CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severityH Mark Kenney, Takeshi Yoshida, Evgeny Berdyshev, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2011
The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infectionsMichael D Howell, Peisong Gao, Byung Eui Kim, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2011
Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ responseDonald Y M Leung, Pei-Song Gao, Dmitry N Grigoryev, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Allergy and Clinical Immunology|April 15, 2011
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitisAnna De Benedetto, Mark K Slifka, Nicholas M Rafaels, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 23, 2023
Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis SkinDonald Y M Leung, Robert Bissonnette, Simion Kreimer, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 14, 2004
Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice ParametersDonald Y M Leung, Richard A Nicklas, James T Li, et al.
Allergy|July 11, 2022
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitisEvgeny Berdyshev, Elena Goleva, Robert Bissonnette, et al.
Dermatology and Therapy|June 2, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) RegistryEric L Simpson, Anna De Benedetto, Mark Boguniewicz, et al.
American Journal of Clinical Dermatology|December 12, 2019
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical TrialAmy S Paller, Ashish Bansal, Eric L Simpson, et al.
The Journal of Allergy and Clinical Immunology|September 29, 2024
CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severityH Mark Kenney, Takeshi Yoshida, Evgeny Berdyshev, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2011
The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infectionsMichael D Howell, Peisong Gao, Byung Eui Kim, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2011
Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ responseDonald Y M Leung, Pei-Song Gao, Dmitry N Grigoryev, et al.
Pageof 16